MDAI (hydro<wbr>chloride)

MDAI (hydrochloride)

CAT N°: 9001102

MDAI is an indane analog of 3,4-(methylenedioxy)amphetamine (MDA), a psychoactive compound. In animal studies, MDAI effects are indistinguishable from 3,4-(methylenedioxy)methamphetamine (MDMA).{20175} While non-neurotoxic in animals when administered alone, MDAI produces significant serotonin neurotoxicity when given with dopaminergic agents.{20174} MDAI has potential for abuse; this product is intended for forensic purposes.

Territorial Availability: Available through Bertin Technologies only in France

Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.

Special Advice: Please check regulation status before ordering; additionel fees can apply.

  • Synonyms
    • 6,7-dihydro-5H-indeno[5,6-d]-1,3-dioxol-6-amine, monohydrochloride
  • Correlated keywords
    • designer drugs forensics MDA MDMA neuroscience neurotoxicity analogs amphetamine serotonin neurotoxin methamphetamine 12440-03-9 13274-81-2 analytical references standards
  • Product Overview:
    MDAI is an indane analog of 3,4-(methylenedioxy)amphetamine (MDA), a psychoactive compound. In animal studies, MDAI effects are indistinguishable from 3,4-(methylenedioxy)methamphetamine (MDMA).{20175} While non-neurotoxic in animals when administered alone, MDAI produces significant serotonin neurotoxicity when given with dopaminergic agents.{20174} MDAI has potential for abuse; this product is intended for forensic purposes.

We also advise you